ARCT logo Arcturus Therapeutics : ARCT

ARCT

Stock Data

$8.63

Change up

$0.01 (0.12%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Arcturus Therapeutics Holdings Inc is a biotechnology firm based in San Diego, California, specializing in the development of innovative mRNA medicines and vaccines. With a focus on addressing infectious diseases, liver, and respiratory rare conditions, Arcturus leverages its proprietary LUNAR lipid-mediated delivery and STARR mRNA technology platforms. The company's pipeline includes ARCT-810, a treatment for ornithine transcarbamylase deficiency in Phase 2 trials, ARCT-154, a COVID-19 vaccine candidate in Phase 3 trials in Vietnam, and ARCT-032, a potential therapy for cystic fibrosis.

All Arcturus Therapeutics Articles

11 Articles